Influenza A showing Tamiflu resistance
Tuesday, January 6th, 2009Gizmorama -
“The Cutting Edge of Science Fact and Science Possibilities”
————————————————————
Good Morning,
One of todays’ articles tells how the FDA approves
Mozobil for transplants. Have A Good Day!
Until Tomorrow,
Erin
————————————————————
Roman Coliseum to host gladiator events
The Roman Coliseum will host several re-enactments next
year of the gladiator battles made famous by the Roman
Empire, a Rome City Council official says. Council head
of archaeology Umberto Broccoli said to honor the 2,000th
anniversary of the birth of Emperor Vespasian, visitors
to the historic site would be able to witness mock com-
bats reminiscent of the infamous Coliseum battles, The
Times of London said Friday. Event organizers have yet
to determine if the historic events will take place in
the famed arena or outside it on a stage. Broccoli said
the orchestrated fights would involve authentic costumes
and weapons in an attempt to educate visitors to the
historic activity. City officials told The Times they
chose to organize the gladiator events instead of pop
concerts in order to protect the Coliseum from poten-
tially damaging vibrations caused by loud music.
————————————————————
TOUGH TOOLS LED TORCH FLASHLIGHT
Normal Price: $4.99
DEAL PRICE: $1.49
Get Two for $1.98
Don’t let the size fool you… This amazing little flashlight
uses nine of the brightest led bulbs available and is one of the
most energy efficient types of flashlights available today! With
its compact size and light weight design makes it really handy
and portable. It’s perfect for camping, travel, boating, home
emergency kits, or even walking the dog! Colors may vary.
FEATURES:
- 100,000 hour LEDs - 120 foot effective range
- Anti-shock structure - Takes 3 AAA Batteries (INCLUDED)
Just 99 cents when you buy two or more…
http://pd.gophercentral.com/r/120/a/474/l/c74sc7
————————————————————
Influenza A showing Tamiflu resistance
The U.S. Centers for Disease Control and Prevention
said Influenza A (H1N1) is showing resistance to the
drug oseltamivir (Tamiflu). The agency based in
Atlanta said patients suspected of having Influenza
A should instead be treated with the antiviral drug
Relenza or a combination Tamiflu and rimantadine.
The CDC issued the health alert advisory Friday after
studying preliminary flu data from a limited number
of states. The CDC said this year’s flu vaccine is
expected to be effective in preventing or reducing
the severity of circulating influenza viruses and
recommends medical personnel continue vaccination
efforts.
———————————————————–
SET OF 2 COLLAPSIBLE BUCKETS
Retail Price: $19.99
Deal Price: $7.99
Bright 3-gallon buckets twist and fold completely flat for
easy storage in garage, trunk, or beach bag! In durable
polyester with sturdy handle, plastic liner, and zipper close,
they tote fresh-picked veggies or fruit, garden clippings,
potting soil, ice and picnic supplies.
Each, 11″ high x 10 1/2″ diameter.
- Holds Water, Weeds, Potting Soil, Tools & more…
- Great for the Garden, Camping & the Beach
- 3 Gallon Capacity
- Twists & Folds for EASY storage
Set includes one red and one blue. Get one set for $7.99
See them by visiting the site at:
http://pd.gophercentral.com/r/120/a/474/l/hq2os0
————————————————————
FDA approves Mozobil for transplants
The U.S. Food and Drug Administration has approved the
drug Mozobil for treatment of adults with multiple mye-
loma or non-Hodgkin’s lymphoma. The drug, manufactured
by Genzyme Corp., Cambridge, Mass., has been found to
help increase the number of blood stem cells for bone
marrow transplantation in patients with certain blood
cancers, the agency said Thursday in a release. Mozobil
is intended to be used in combination with the growth
factor granulocyte-colony stimulating factor. “Collect-
ing the millions of cells needed for a bone marrow
transplant can take hours or days,” Dr. Richard Pazdur,
of the FDA’s Center for Drug Evaluation and Research,
said. “Mozobil provides a new therapeutic option for
patients with certain types of blood cancers by increas-
ing the number of stem cells collected in a given time
period to be re-infused after therapy.”